Eric Crombez serves as Executive at Ultragenyx Pharmaceutical Inc., where they oversee executive responsibilities. Since joining the company, Eric Crombez has executed 8 insider transactions totaling $203.9K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 2, 2026 involved selling 16,284 shares valued at $82.9K.
Eric Crombez currently holds 63,456 shares of Ultragenyx Pharmaceutical Inc. (RARE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Eric Crombez has been a net seller of RARE stock. They have purchased $0 and sold $203.9K worth of shares.
Eric Crombez's most recent insider trade was on Feb 2, 2026, when they sold 16,284 shares at $5.09 per share.
Get notified when new Form 4 filings are submitted
| $6.93 |
| Discretionary |
| Aug 13, 2024 | ABEO | $0 | Award | 11,044 | $N/A | Discretionary |
| May 2, 2024 | RARE | $15.5K | Sale | 354 | $43.66 | Discretionary |
| Apr 18, 2024 | RARE | $6.3K | Sale | 142 | $44.10 | Discretionary |
| Mar 1, 2024 | RARE | $66.6K | Sale | 1,238 | $53.76 | Discretionary |
| Mar 1, 2024 | RARE | $0 | Award | 19,400 | $N/A | Discretionary |
| May 1, 2023 | RARE | $0 | Award | 4,658 | $N/A | Discretionary |